Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration 

          - 21 CFR Part 510 

# AGENCY:

Food and Drug Administration, HHS. 

# ACTION:

Final rule.

# SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name and address for Global Pharmaceutical Corp. 

# DATES:

This rule is effective May 3, 2000. 

# FOR FURTHER INFORMATION CONTACT:

Thomas J. McKay, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0213. 

# SUPPLEMENTARY INFORMATION:

Global Pharmaceutical Corp., Castor and Kensington Aves., Philadelphia, PA 19124, has informed FDA of a change of sponsor's name and address to IMPAX Laboratories, Inc., 30831 Huntwood Ave., Hayward, CA 94544. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change of sponsor's name and address. 

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. 

      ( print page 25642)    

# List of Subjects in 21 CFR Part 510

      - Administrative practice and procedure
      - Animal drugs
      - Labeling
      - Reporting and recordkeeping requirements

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: 

# PART 510—NEW ANIMAL DRUGS 

1. The authority citation for 21 CFR part 510 continues to read as follows: 

Authority:21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 

§ 510.600 

2. Section 510.600 *Names, addresses, and drug labeler codes of sponsors of approved applications*                         is amended in the table in paragraph (c)(1) by removing the entry for “Global Pharmaceutical Corp.” and by alphabetically adding an entry for “IMPAX Laboratories, Inc., 30831 Huntwood Ave., Hayward, CA 94544”; and in the table in paragraph (c)(2) in the entry for “000115” by removing the sponsor name and address and by adding their place “IMPAX Laboratories, Inc., 30831 Huntwood Ave., Hayward, CA 94544.                     

Dated: April 24, 2000. 

Claire M. Lathers, 

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. 

[FR Doc. 00-10932 Filed 5-2-00; 8:45 am] 

BILLING CODE 4160-01-F